Kiora Pharmaceuticals, Inc. announced that effective as of June 16, 2022, Drexler resigned as Interim Chief Financial Officer of the Company, but will continue to provide consulting services to the Company pursuant to the Consulting Agreement. Drexler's resignation did not result from any disagreement regarding the Company's operations, policies or practices. In connection with Drexler's resignation, Brian M. Strem, Ph.D., the Company's President and Chief Executive Officer, will assume the role of the Company's principal financial and accounting officer.